buy depth looks great, page-53

It just doesn't like that level while they've built the cash which is what I really wanted to see I still think it's pretty mute for a while with the value now up above $200M. I know you've got your long lists Tony of expected value points but I'm in two mind if it's stretching value to far here - still at least 6 months before any results start filtering through & that's where the real value add will come from with the exception of Perseis but...... A lot happening early '14 in regards to moving trials forward & initiating but I think at these values it really needs to be backing some results from the clinic which start coming heavily 2H 2014 and into '15 if timelines hold. It still might get the 17c target soon but in absence of a black swan event can it go higher ? Don't know.

Just my 2 cents :-)